Sino Medical Sciences Technology In Cash Flow Conversion Efficiency
Sino Medical Sciences Technology In cash flow conversion efficiency. Based on the latest financial reports, Sino Medical Sciences Technology In (688108) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥31.52 Million ≈ $4.61 Million USD) by net assets (CN¥931.81 Million ≈ $136.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sino Medical Sciences Technology In (2016–2025)
Cash flow conversion efficiency of Sino Medical Sciences Technology In from 2016 to 2025. This chart illustrates how Sino Medical Sciences Technology In's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sino Medical Sciences Technology In stock quote for real-time trading data and today's change.
Sino Medical Sciences Technology In Cash Flow Conversion Ratio Explained
Sino Medical Sciences Technology In cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sino Medical Sciences Technology In Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sino Medical Sciences Technology In ranked by their cash flow conversion efficiency. Also see Sino Medical Sciences Technology In (688108) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yieh Phui Enterprise Co Ltd
TW:2023
|
0.038x |
|
SP Group A/S
CO:SPG
|
0.069x |
|
Chutian Dragon Co Ltd
SHE:003040
|
0.055x |
|
Zhongtong Bus Holding Co Ltd
SHE:000957
|
0.109x |
|
Shenzhen Farben Information Technology Co.Ltd.
SHE:300925
|
N/A |
|
Zhejiang Kaier New Materials
SHE:300234
|
0.026x |
|
Ningbo Sunrise Elc Technology Co Ltd Class A
SHE:002937
|
0.021x |
|
Mivtach Shamir
TA:MISH
|
-0.050x |
Annual Cash Flow Conversion Efficiency for Sino Medical Sciences Technology In (2016–2025)
The table below shows the annual cash flow conversion efficiency of Sino Medical Sciences Technology In from 2016 to 2025. Review Sino Medical Sciences Technology In free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.28 Billion ≈ $333.85 Million |
CN¥161.87 Million ≈ $23.69 Million |
0.071x | -51.43% |
| 2024-12-31 | CN¥898.34 Million ≈ $131.46 Million |
CN¥131.24 Million ≈ $19.20 Million |
0.146x | +121.46% |
| 2023-12-31 | CN¥861.65 Million ≈ $126.09 Million |
CN¥56.84 Million ≈ $8.32 Million |
0.066x | +152.59% |
| 2022-12-31 | CN¥887.48 Million ≈ $129.87 Million |
CN¥-111.31 Million ≈ $-16.29 Million |
-0.125x | -97.14% |
| 2021-12-31 | CN¥945.16 Million ≈ $138.31 Million |
CN¥-60.13 Million ≈ $-8.80 Million |
-0.064x | -197.25% |
| 2020-12-31 | CN¥1.08 Billion ≈ $157.73 Million |
CN¥70.51 Million ≈ $10.32 Million |
0.065x | -47.78% |
| 2019-12-31 | CN¥1.10 Billion ≈ $160.75 Million |
CN¥137.61 Million ≈ $20.14 Million |
0.125x | -9.96% |
| 2018-12-31 | CN¥701.28 Million ≈ $102.62 Million |
CN¥97.56 Million ≈ $14.28 Million |
0.139x | +20.02% |
| 2017-12-31 | CN¥606.70 Million ≈ $88.78 Million |
CN¥70.32 Million ≈ $10.29 Million |
0.116x | -44.37% |
| 2016-12-31 | CN¥202.75 Million ≈ $29.67 Million |
CN¥42.24 Million ≈ $6.18 Million |
0.208x | -- |
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Science… Read more